sibp-01
Showing 1 - 1 of 1
HER2-positive Early Breast Cancer Trial in Shanghai (SIBP-01, Herceptin, Docetaxel)
Unknown status
- HER2-positive Early Breast Cancer
- SIBP-01
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 15, 2019